![Mathieu Simon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mathieu Simon
Directeur/Membre du Conseil chez
IDORSIA LTD
Fortune : 543 345 $ au 31/05/2026
Profil
Le Dr Mathieu Simon est président d'Epsilen Bio SRL, président d'Idorsia Ltd, administrateur indépendant d'Asarina Pharma AB, administrateur indépendant de Vaximm AG, président d'Idorsia Pharmaceuticals Ltd, directeur général de Cellectis Therapeutics et administrateur indépendant de LNC Therapeutics SA. Il siège au conseil d'administration de Lysogene SA, Asarina Pharma AB, Affimed NV, Affimed GmbH, Vaximm AG, Messier Maris & Associs SCA et LNC Therapeutics SA. Auparavant, le Dr Simon a occupé les postes de vice-président exécutif, directeur des opérations et directeur médical chez Cellectis SA, de vice-président du marketing et des affaires médicales chez Wyeth Pharmaceuticals LLC, de vice-président du groupe du marketing et des affaires cliniques chez Wyeth-Ayerst International, Inc. et de premier vice-président des opérations mondiales chez Pierre Fabre Mdicament SAS, de directeur général et de chef de la division Pharma mondiale chez Pierre Fabre SA et de président-directeur général chez Takara Bio Europe AB. Il a également siégé au conseil d'administration d'Alliance for Regenerative Medicine, d'Ectycell SASU et de Farmindustria.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
IDORSIA LTD. 0,04% | 31/12/2024 | 95 061 ( 0,04% ) | 543 345 $ | 31/05/2026 |
Postes actifs de Mathieu Simon
| Sociétés | Poste | Début |
|---|---|---|
| IDORSIA LTD | Directeur/Membre du Conseil | 13/06/2024 |
Aileens Pharma Srl
 Aileens Pharma Srl Miscellaneous Commercial ServicesCommercial Services Engages in research and experimental development on biotechnology | Président | - |
Idorsia Pharmaceuticals Ltd.
 Idorsia Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceuticals | Président | 13/05/2020 |
Messier Maris & Associés SCA
 Messier Maris & Associés SCA Investment ManagersFinance Provides financial consulting and investment advisory services | Directeur/Membre du Conseil | - |
Epsilen Bio Srl
 Epsilen Bio Srl Pharmaceuticals: MajorHealth Technology Develops therapies for genetic diseases | Président | 15/06/2020 |
Affimed GmbH
 Affimed GmbH Miscellaneous Commercial ServicesCommercial Services Provides business and private economic services | Directeur/Membre du Conseil | 01/01/2018 |
Anciens postes connus de Mathieu Simon
| Sociétés | Poste | Fin |
|---|---|---|
| AFFIMED N.V. | Directeur/Membre du Conseil | 26/06/2024 |
| CELLECTIS S.A. | Directeur Technique/Scientifique/R&D | 14/03/2018 |
Cellectis Therapeutics | Directeur Général | 01/02/2014 |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░ ░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Mathieu Simon
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
32
Relations au 1er degré
22
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 22 |
|---|---|
Wyeth Pharmaceuticals LLC
 Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets infant pharmaceutical products | Health Technology |
Affimed NV
 Affimed NV Pharmaceuticals: MajorHealth Technology Discovers and develops antibody-based therapeutic drugs | Health Technology |
Pierre Fabre SA
 Pierre Fabre SA BiotechnologyHealth Technology Engages in research and preclinical development of biologics & pharmaceuticals | Health Technology |
Pierre Fabre Médicament SAS
 Pierre Fabre Médicament SAS Pharmaceuticals: OtherHealth Technology Manufactures cosmetics and pharmaceutical products | Health Technology |
Cellectis SA
 Cellectis SA Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops immunotherapies | Health Technology |
Université Paris Diderot-Paris 7
 Université Paris Diderot-Paris 7 Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Takara Bio Europe AB
 Takara Bio Europe AB Miscellaneous Commercial ServicesCommercial Services Develops hepatocytes and cardiomyocytes from the proprietary stem cells | Commercial Services |
Vaximm AG
 Vaximm AG Miscellaneous Commercial ServicesCommercial Services Develops immunotherapies for cancer treatment | Commercial Services |
Asarina Pharma AB
 Asarina Pharma AB Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Health Services |
Messier Maris & Associés SCA
Messier Maris & Associés SCA Investment ManagersFinance Provides financial consulting and investment advisory services | Finance |
Ectycell SASU
 Ectycell SASU BiotechnologyHealth Technology Produces and sales stem cells | Health Technology |
YSOPIA Biosciences SA
 YSOPIA Biosciences SA BiotechnologyHealth Technology Develops therapeutic solutions for metabolic and cardiometabolic disorders | Health Technology |
Wyeth-Ayerst International LLC | |
Lysogene SA
 Lysogene SA BiotechnologyHealth Technology Engages in research and clinical development of gene therapy for neurodegenerative disorders | Health Technology |
Farmindustria
 Farmindustria Miscellaneous Commercial ServicesCommercial Services Operates as a healthcare organization | Commercial Services |
Idorsia Ltd.
 Idorsia Ltd. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development and commercialization of medicines for unmet medical needs | Health Technology |
Aileens Pharma Srl
Aileens Pharma Srl Miscellaneous Commercial ServicesCommercial Services Engages in research and experimental development on biotechnology | Commercial Services |
Idorsia Pharmaceuticals Ltd.
Idorsia Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceuticals | Health Technology |
Affimed GmbH
Affimed GmbH Miscellaneous Commercial ServicesCommercial Services Provides business and private economic services | Commercial Services |
Epsilen Bio Srl
Epsilen Bio Srl Pharmaceuticals: MajorHealth Technology Develops therapies for genetic diseases | Health Technology |
Cellectis Therapeutics |
